Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis
- PMID: 19818304
- DOI: 10.1016/j.cld.2009.07.009
Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis
Abstract
It is well established that the development of NAFLD and NASH are closely linked to an excess flow of free fatty acids (FFA) arising from dysfunctional/insulin resistant adipose tissue causing ectopic fat deposition in many organs. In the liver, when chronic lipid supply surpasses the metabolic ability to adapt it will induce hepatocellular damage as FFA are redirected into harmful pathways of non-oxidative metabolism with intracellular accumulation of toxic lipid-derived metabolites. Multiple mechanisms have been implicated including mitochondrial dysfunction, endoplasmic reticulum stress, and activation of multiple inflammatory pathways. Understanding the role of insulin resistance and lipotoxicity in NASH as part of a broader metabolic disorder is likely to assist practitioners in the successful management of these challenging patients.
Similar articles
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8. Gastroenterology. 2012. PMID: 22326434 Review.
-
A fresh look at NASH pathogenesis. Part 1: the metabolic movers.J Gastroenterol Hepatol. 2010 Apr;25(4):672-90. doi: 10.1111/j.1440-1746.2010.06253.x. J Gastroenterol Hepatol. 2010. PMID: 20492324 Review.
-
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.Trends Mol Med. 2006 Dec;12(12):555-8. doi: 10.1016/j.molmed.2006.10.001. Epub 2006 Oct 17. Trends Mol Med. 2006. PMID: 17049925
-
From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):146-52. doi: 10.1016/j.numecd.2008.10.010. Epub 2009 Jan 25. Nutr Metab Cardiovasc Dis. 2009. PMID: 19171470 Review.
-
From a glucocentric to a lipocentric approach towards metabolic syndrome.Drug Discov Today. 2008 Mar;13(5-6):211-8. doi: 10.1016/j.drudis.2008.01.006. Epub 2008 Mar 7. Drug Discov Today. 2008. PMID: 18342796 Review.
Cited by
-
The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.J Physiol Biochem. 2023 Nov;79(4):815-831. doi: 10.1007/s13105-022-00913-5. Epub 2022 Aug 26. J Physiol Biochem. 2023. PMID: 36018492 Review.
-
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines.Front Neurosci. 2022 Nov 15;16:1042442. doi: 10.3389/fnins.2022.1042442. eCollection 2022. Front Neurosci. 2022. PMID: 36458039 Free PMC article. Review.
-
Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.Int J Clin Exp Med. 2015 Mar 15;8(3):3924-34. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064294 Free PMC article.
-
GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.PLoS One. 2011;6(9):e25269. doi: 10.1371/journal.pone.0025269. Epub 2011 Sep 21. PLoS One. 2011. PMID: 21957486 Free PMC article.
-
Plasma concentrations of zonulin are elevated in obese men with fatty liver disease.Diabetes Metab Syndr Obes. 2018 Apr 23;11:149-157. doi: 10.2147/DMSO.S163062. eCollection 2018. Diabetes Metab Syndr Obes. 2018. PMID: 29719415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources